Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myocardin-related transcription factor's interaction with serum-response factor is critical for outgrowth initiation, progression, and metastatic colonization of breast cancer cells. | FASEB Bioadv | 2022 | 35949508 | PubTator, text mining | PubMed |
| PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation. | Proc Natl Acad Sci U S A | 2022 | 35939690 | PubTator, text mining | PubMed |
| Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19. | Front Cell Infect Microbiol | 2022 | 35937696 | PubTator, text mining | PubMed |
| Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2022 | 35935869 | PubTator, text mining | PubMed |
| Early Prediction of COVID-19 Patient Survival by Targeted Plasma Multi-Omics and Machine Learning. | Mol Cell Proteomics | 2022 | 35931319 | PubTator, text mining | PubMed |
| Intracellular flow cytometry staining of antibody-secreting cells using phycoerythrin-conjugated antibodies: pitfalls and solutions. | Antib Ther | 2022 | 35928457 | PubTator, text mining | PubMed |
| Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort. | Haematologica | 2022 | 35924579 | PubTator, text mining | PubMed |
| Methods to capture proteomic and metabolomic signatures from cerebrospinal fluid and serum of healthy individuals. | Sci Rep | 2022 | 35922450 | PubTator, text mining | PubMed |
| Modulation of pre-mRNA structure by hnRNP proteins regulates alternative splicing of MALT1. | Sci Adv | 2022 | 35921415 | PubTator, text mining | PubMed |
| Fighting fibrosis. | Nat Biotechnol | 2022 | 35915352 | PubTator, text mining | PubMed |
| The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells. | Front Cell Infect Microbiol | 2022 | 35909969 | PubTator, text mining | PubMed |
| Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack? | J Recept Signal Transduct Res | 2022 | 35895308 | PubTator, text mining | PubMed |
| Prognosis of Alzheimer's Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning. | Int J Mol Sci | 2022 | 35887259 | PubTator, text mining | PubMed |
| Pentraxin 3 in Circulating Microvesicles: a Potential Biomarker for Acute Heart Failure After Cardiac Surgery with Cardiopulmonary Bypass. | J Cardiovasc Transl Res | 2022 | 35879589 | PubTator, text mining | PubMed |
| Serum pentraxin 3 concentration correlates with disease severity in patients with myasthenia gravis. | Clin Neurol Neurosurg | 2022 | 35878561 | PubTator, text mining | PubMed |
| The correlation analysis of TERT promoter mutations with IDH1/2 mutations and 1p/19q detected in human gliomas. | Medicine (Baltimore) | 2022 | 35866817 | PubTator, text mining | PubMed |
| Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells. | Front Immunol | 2022 | 35865550 | PubTator, text mining | PubMed |
| PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma. | CNS Neurosci Ther | 2022 | 35855654 | PubTator, text mining | PubMed |
| TNFAIP6 Promotes Gastric Carcinoma Cell Invasion via Upregulating PTX3 and Activating the Wnt/β-Catenin Signaling Pathway. | Contrast Media Mol Imaging | 2022 | 35854776 | PubTator, text mining | PubMed |
| Extended DNA-binding interfaces beyond the canonical SAP domain contribute to the function of replication stress regulator SDE2 at DNA replication forks. | J Biol Chem | 2022 | 35850305 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=19